Clinical trials
Phase 2 Biliary Tract Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 8 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 7 |
| Terminated | 7 |
| Active, not recruiting | 6 |
| Withdrawn | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| National Cancer Institute (NCI) | 4 |
| AstraZeneca | 3 |
| University of Michigan Rogel Cancer Center | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| Bayer | 2 |
| Georgetown University | 2 |
| Jazz Pharmaceuticals | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Ambrx, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 50 |
| Cholangiocarcinoma | 14 |
| Gallbladder Neoplasms | 11 |
| Carcinoma, Hepatocellular | 6 |
| Colorectal Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Bile Duct Neoplasms | 5 |
| Breast Neoplasms | 5 |
| Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.